Association Between Hemoglobin A1c and Development of Cardiovascular Disease in Canadian Men and Women Without Diabetes at Baseline: A Population‐Based Study of 608 474 Adults
Open Access
- 7 May 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (9) , e031095
Abstract
Background: We examined the association between hemoglobin A1c (HbA1c) and the development of cardiovascular disease (CVD) in men and women, without diabetes or CVD at baseline. Methods and Results: This retrospective cohort study included adults aged 40 to <80 years in Alberta, Canada. Men and women were divided into categories based on a random HbA1c during a 3‐year enrollment period. The primary outcome of CVD hospitalization and secondary outcome of combined CVD hospitalization/mortality were examined during a 5‐year follow‐up period until March 31, 2021. A total of 608 474 individuals (55.2% women) were included. Compared with HbA1c 5.0% to 5.4%, men with HbA1c of 5.5% to 5.9% had an increased risk of CVD hospitalization (adjusted hazard ratio [aHR], 1.12 [95% CI, 1.07–1.19]) whereas women did not (aHR, 1.01 [95% CI, 0.95–1.08]). Men and women with HbA1c of 6.0% to 6.4% had a 38% and 17% higher risk and men and women with HbA1c ≥6.5% had a 79% and 51% higher risk of CVD hospitalization, respectively. In addition, HbA1c of 6.0% to 6.4% and HbA1c ≥6.5% were associated with a higher risk (14% and 41%, respectively) of CVD hospitalization/death in men, but HbA1c ≥6.5% was associated with a 24% higher risk only among women. Conclusions: In both men and women, HbA1c ≥6.0% was associated with an increased risk of CVD and mortality outcomes. The association between CVD and HbA1c levels of 5.5% to 5.9%, considered to be in the “normal” range, highlights the importance of optimizing cardiovascular risk profiles at all levels of glycemia, especially in men.Keywords
This publication has 28 references indexed in Scilit:
- Disparities in adherence to diabetes screening guidelines among males and females in a universal care setting: A population-based study of 1,380,697 adultsThe Lancet Regional Health - Americas, 2022
- Glycated Hemoglobin and Subclinical Atherosclerosis in People Without DiabetesJACC, 2021
- Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic SyndromeCanadian Journal of Diabetes, 2018
- Screening for Diabetes in AdultsCanadian Journal of Diabetes, 2018
- Glycated Hemoglobin Measurement and Prediction of Cardiovascular DiseaseJAMA, 2014
- Pitfalls in Hemoglobin A1c Measurement: When Results may be MisleadingJournal of General Internal Medicine, 2013
- Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelinesBritish Journal of Cancer, 2004
- Gaining more flexibility in Cox proportional hazards regression models with cubic spline functionsComputer Methods and Programs in Biomedicine, 1997
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987